4//SEC Filing
Spellman Mary 4
Accession 0001566044-18-000013
CIK 0001566044other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:43 PM ET
Size
5.3 KB
Accession
0001566044-18-000013
Insider Transaction Report
Form 4
Spellman Mary
Chief Medical Officer
Transactions
- Award
Stock Option
2018-12-10+96,000→ 96,000 totalExercise: $5.51Exp: 2028-12-10→ Common Stock (96,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.
Documents
Issuer
Menlo Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001740108
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:43 PM ET
- Size
- 5.3 KB